GLUE pioneered in Yorkshire, as an alternative to stitching or stapling tissue together after surgery, is set to be used worldwide on patients. The innovative surgical adhesive was first used on victims injured in the Bradford City fire in 1985.
It had been developed in research over the previous decade at hospitals in Bradford and has been used across Europe for the last five years.
Now the product, marketed as Indermil, has won approval from the US Federal Food and Drug Administration, giving it an international licence.
Its inventor, Prof Alan Roberts, consultant clinical scientist at Bradford Hospitals NHS Trust, said the decision would enable people around the world to benefit.
"Research has shown that tissue adhesives provide a safe alternative to suturing, packing, or stapling planes of tissue together. Indermil provides a fast-acting and complete closure of the wound, thereby reducing the amount of blood loss and minimising scarring.
"It works very quickly, usually completely closing the wound within 10 seconds, and also has an anaesthetic effect to help numb any pain."
The adhesive is now also used by vets on animals which need operations.